Anthropic launched Claude for Life Sciences and announced collaborations with 10x Genomics and Benchling to enable natural‑language interrogation of single‑cell and other datasets. The product targets lab workflows, data interrogation and hypothesis generation, framing LLMs as operational tools for research teams. Separately, Genomics unveiled Mystra, an AI‑enabled human genetics platform built on its large genotype‑phenotype database to accelerate drug target discovery and validation. Mystra packages harmonized GWAS datasets and machine learning tools for target prioritization, reflecting growing investor and industry demand for AI that operationalizes human genetics to de‑risk target selection.